Research
The introduction of mammography screening programs in Europe has significantly changed breast cancer diagnoses, accompanied by a decline in breast cancer mortality rates. This is shown by one of the most comprehensive analyses of population-based data on breast cancer in 21 European countries to date, led by the German Cancer Research Center (DKFZ). The most […]
read more
Universität Heidelberg Defends its Status as a University of Excellence
Rector Frauke Melchior: “A fantastic joint effort led to success” Heidelberg University has been successful in all previous rounds of the excellence competition and, in the current funding round, has convincingly defended its status as a University of Excellence. That announcement came today (Wednesday, 11 March 2026) from the German Science and Humanities Council and […]
read more
Drug development: New NMI framework reduces risk of costly failure
How can the risk of failure in the development of drug compounds be reduced? In a recent paper, researchers at the NMI present a newly developed framework that makes the development of drug compounds from so-called single-domain antibodies (sdAb) safer and more reliable. Until now, drug development has generally proceeded as follows: one starts with […]
read more
FGK Clinical Research establishes operational presence in the Netherlands to bolster European clinical trial landscape
[Munich, 10/03/2026] — FGK Clinical Research GmbH, a leading full-service Contract Research Organization (CRO) headquartered in Germany, is thrilled to announce the further expansion of its operative team in the Netherlands. This strategic regional expansion strengthens FGK’s European presence and commitment to high-quality clinical research services. The local Dutch team will support clinical studies in the […]
read more
Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital
Ladenburg, Germany, 9 March 2026 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), announced on 7 March an additional amendment to its existing royalty purchase agreement with HealthCare Royalty (HCRx) and the participation of Soleus Capital Management, L.P. (Soleus Capital), a US-based life sciences investment firm, on behalf […]
read more
A human mini-bladder shows the culprit of recurrent infections
Researchers at EPFL, Heidelberg University and Roche have built a human mini-bladder to show how urine composition weakens bladder tissue, helping infections recur even after antibiotics. The bladder is not just a static storage bag; its lining stretches, relaxes, and stays in constant contact with urine whose composition changes with hydration, diet, and disease. Urine […]
read more
Still among the world’s best: Heidelberg University Hospital to remain one of the top hospitals in 2026
According to the US magazine Newsweek, Heidelberg University Hospital (UKHD) remains one of the best hospitals in the world. For its “World’s Best Hospitals 2025” ranking, Newsweek teamed up with the data platform Statista to examine 2,500 hospitals in 32 countries. The UKHD came in 12th place worldwide. In Germany, the UKHD ranks second—only Berlin’s […]
read more
Hardware for humanoid robots: New perspectives for industrial value creation in Europe
Together with the management consultancy P3, Fraunhofer IPA has investigated how component manufacturers could benefit from producing hardware components for humanoid robots. The results are available free of charge in the white paper “The Humanoid Hardware Value Chain: Can the European Manufacturing Industry Capitalize on the Humanoid Momentum?” Humanoid robots are currently developing at a […]
read more
2025 business results – Roche in Germany reports positive results: Roche defies the trend and invests over 700 million euros in Germany
While large parts of the German economy are stagnating, Roche is sending an encouraging signal for Germany as a business location: in fiscal year 2025, the company invested over €700 million in its German sites and increased its sales by 4.7 percent to €8.9 billion. This growth is based on targeted investments in medical progress […]
read more
